STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway

• Ran Wang,
• Jianghong Cai,
• Keyuan Chen,
• Menglin Zhu,
• Zhaoyi Li,
• Hua Liu,
• Tiantian Liu,
• Jianchun Mao,
• Qian Ding,
• Yi Zhun Zhu

Affiliations

Ran Wang

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Jianghong Cai

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Keyuan Chen

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Menglin Zhu

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Zhaoyi Li

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Hua Liu

Department of Pharmacy, Aerospace Center Hospital

Tiantian Liu

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Jianchun Mao

Department of Rheumatology, Longhua Hospital of Shanghai University of Traditional Chinese Medicine

Qian Ding

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long

Yi Zhun Zhu

State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long